Adipogenesis and metabolic health
By Alexandra L. Ghaben, P. Scherer. Nature reviews. Molecular cell biology, 2019
1,228 citations recorded by the source corpus.
Subfields: Cardiology and Cardiovascular Medicine, Epidemiology, Physiology
View Paper: https://www.semanticscholar.org/paper/4fcd08092b207de7bf166354cd3000e12504500a
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Cardiology and Cardiovascular Medicine
In Epidemiology
- A. Chait
- Laura J. den Hartigh
- Jamal Naderi
- Alexander Sakers
- M. Longo
- C. Miele
- Mirian Krystel De Siqueira
- G. A. Raciti
In Physiology
- A. Chait
- Laura J. den Hartigh
- Jamal Naderi
- Alexander Sakers
- M. Longo
- C. Miele
- Mirian Krystel De Siqueira
- G. A. Raciti
Citations in the corpus
- Adipose tissue plasticity in health and disease (2022, background): “Proadipogenic signals include: insulin; bone-morphogenic-protein (BMP) signaling (especially BMP2 and BMP4); and ECM composition (Ghaben and Scherer, 2019).”
- Adipose Tissue Dysfunction as Determinant of Obesity-Associated Metabolic Complications (2019, background): “However, recent insights highlight the concept that proper adipose tissue remodeling requires activation of an acute and transient inflammatory response [72].”
- Metabolically Healthy Obesity (2020, methodology): “Our data supports models for the development of MUO (60, 61) in which ectopic fat and impaired adipose tissue function may lead to systemic insulin resistance, lipotoxicity, and a proinflammatory state and could, therefore, play a causal role in the transition from MHO to MUO (Fig.”
- Adipose Tissue Distribution, Inflammation and Its Metabolic Consequences, Including Diabetes and Cardiovascular Disease (2020, background): “, the ability to distribute fat among newly differentiated adipocytes without the need for significant hypertrophy) mitigates such inflammation and subsequent insulin resistance (388).”